Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Oluwaranti, Akiyode"'
Autor:
Jeremy A. Hughes, Tonya Martin, Timothy D. Gladwell, Oluwaranti Akiyode, Miriam C. Purnell, Mohd Shahid, Aisha Morris Moultry, Kristi Isaac Rapp, Jacqueise Unonu
Publikováno v:
Currents in Pharmacy Teaching and Learning.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::590b6023a729febc0595c4a81f312bfd
https://doi.org/10.1016/j.cptl.2023.05.004
https://doi.org/10.1016/j.cptl.2023.05.004
Publikováno v:
The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians. 32(1)
Objective: To evaluate the pharmacotherapy role of ranibizumab, a vascular endothelial growth factor (VEGF) inhibitor, for the treatment of diabetic retinopathy (DR) in patients with diabetic macular edema (DME). Data Sources: PubMed, Science Direct,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd55cb5cb2718d3c3ca57784a12a4dae
https://pubmed.ncbi.nlm.nih.gov/34860956
https://pubmed.ncbi.nlm.nih.gov/34860956
Autor:
Oluwaranti Akiyode, Adebola A. Adesoye
Publikováno v:
Journal of Pharmacy Practice. 30:238-244
The increasing number of newer type 2 diabetes therapies has allowed providers an increased armamentarium for the optimal management of patients with diabetes. In fact, these newer agents have unique benefits in the management of type 2 diabetes. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6a5a07cc84f7eea0867aaa2eace6537
https://doi.org/10.1177/0897190015594732
https://doi.org/10.1177/0897190015594732
Autor:
Oluwaranti Akiyode, Christine Tran
Publikováno v:
Diabetes Spectrum : A Publication of the American Diabetes Association
Diabetes has been increasing in prevalence over the years, and nearly 30 million Americans (9.3%) now have diabetes (1). This disease burden on the population also translates to increased prevalence rates of diabetes complications. Diabetes is associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6c2308685d7cb0f53ace969b530ae4
https://doi.org/10.2337/diaspect.29.1.44
https://doi.org/10.2337/diaspect.29.1.44
Autor:
Oluwaranti Akiyode
Publikováno v:
AADE in Practice. 3:38-42
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3da2d41db500c83270aeea754f3c4001
https://doi.org/10.1177/2325160315606950
https://doi.org/10.1177/2325160315606950
Autor:
Oluwaranti Akiyode
Publikováno v:
Currents in Pharmacy Teaching and Learning. 8:584-586
Professionalism is a relevant topic of discussion among all pharmacy schools in the United States because it is now a highly emphasized element in the pharmacy education standards. It behooves pharmacy programs to ensure the proper teaching of profes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::825ecadb39b6aeba04299bd9d65a5277
https://doi.org/10.1016/j.cptl.2016.03.011
https://doi.org/10.1016/j.cptl.2016.03.011
Publikováno v:
Topics in Geriatric Rehabilitation. 29:179-186
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7d5c13a53536ce4cd493f0d2d0acac9
https://doi.org/10.1097/tgr.0b013e31828aef5d
https://doi.org/10.1097/tgr.0b013e31828aef5d
Publikováno v:
Journal of pharmacy practice. 30(5)
Aflibercept is the most recently approved vascular endothelial growth factor (anti-VEGF) inhibitor for the management of diabetic macular edema and diabetic retinopathy. The purpose of this article is to review the efficacy and safety of aflibercept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e21f70e3d0cd0e45ba708c0cb41a8911
https://pubmed.ncbi.nlm.nih.gov/27166390
https://pubmed.ncbi.nlm.nih.gov/27166390
Publikováno v:
American Journal of Health-System Pharmacy. 69:2002-2005
Purpose Privileges for administering nonvaccine injectable medications among pharmacists in the United States were assessed. Methods An e-mail inquiry on specific protocols for the administration of injectables was sent to the state boards of pharmac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7668ad077ef5d8f286c5ffefecee43
https://doi.org/10.1093/ajhp/69.22.2002
https://doi.org/10.1093/ajhp/69.22.2002
Autor:
Oluwaranti Akiyode
Publikováno v:
AADE in Practice. 3:44-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf90a9b39e682dc05f381730dd3b956f
https://doi.org/10.1177/2325160315607229
https://doi.org/10.1177/2325160315607229